FOLX Health’s Post

In today’s news to know: a study published in JAMA Pediatrics, co-authored by FOLX Health researcher Jae Corman, PhD, provides critical insights into the prevalence of gender-affirming medical care among U.S. adolescents. The study analyzed insurance data from 2018 to 2022, finding that fewer than 1 in 1,000 adolescents received puberty blockers or hormones during this period. These findings highlight the rarity of such treatments and underscore the importance of data-driven discussions in the current landscape of transgender youth healthcare. At FOLX Health, we remain committed to advancing inclusive, evidence-based care for the LGBTQ+ community. https://lnkd.in/gzXPiG8e #TransgenderHealth #GenderAffirmingCare #LGBTQHealth #FOLXHealth #InclusiveHealthcare

To view or add a comment, sign in

Explore topics